Joy M. Oriol

Interrupting the transmission of extensively drug-resistant tuberculosis is the most important factor in curtailing the epidemic areas of high disease burden.

HIV PEP preferred regimen Stribild seems to be a good option for immunocompetent people without HIV infection due to the ease of use and tolerable adverse effect profile.